CLOs on the Move

Office of the National Coordinator for Health In

www.healthit.gov

 
The Office of the National Coordinator for Health Information Technology (ONC) is the lead agency charged with formulating the federal government’s health IT strategy and coordinating federal health IT policies, standards, programs, and investments. ONC is organizationally located within the Office of the Secretary for the U.S. Department of Health and Human Services (HHS). The position of National Coordinator was created in 2004, through an Executive Order, and legislatively mandated in the Health Information Technology for Economic and Clinical Health Act (HITECH Act) of 2009.
  • Number of Employees: 100-250
  • Annual Revenue: $10-50 Million
  • www.healthit.gov
  • 330 C Street SW Floor 7
    Washington, DC USA 20201
  • Phone: 202.690.7151

Executives

Name Title Contact Details

Similar Companies

Urology Associates of North texas

Urologist Dallas Texas Medical City Hospital Robotic & Laparoscopic Surgery Prostate & Kidney UANT Urology Associates of North Texas Richard Bevan-Thomas MD enlarged prostate treatment vasectomy incontinence Dallas Plano Mesquite Garland Richardson

Otsego Memorial Hospital

Otsego Memorial Hospital is one of the leading providers in Healthcare, Pharmaceuticals, & Biotech. It is based in Gaylord, MI. To find more information about Otsego Memorial Hospital, please visit www.myomh.org

Eastern Long Island Hospital

Eastern Long Island Hospital is one of the leading providers in Healthcare, Pharmaceuticals, & Biotech. It is based in Greenport, NY. To find more information about Eastern Long Island Hospital, please visit www.elih.org

ENABLE Healthcare Communications

ENABLE Healthcare Communications is a Herndon, VA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Symbiomix Therapeutics

Symbiomix (sim-bye-OH-mix) is a late-stage, privately held biopharmaceutical company developing innovative medicines for serious women`s health infections that have been long neglected and are in need of new therapeutic options. Symbiomix was founded in 2012 by a team of experienced industry professionals and entrepreneurs and is backed by three of the world`s leading healthcare venture capital firms, OrbiMed, Fidelity Biosciences and HBM Partners. The Company`s lead product is SYM-1219, a novel drug candidate containing secnidazole, which is a next generation 5-nitroimidazole antibiotic. Symbiomix is based in New Jersey, with additional offices in Maryland and Connecticut.